NCT05728931View on ClinicalTrials.gov

New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes

Active, not recruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

January 15, 2022

Primary Completion Date

January 15, 2026

Study Completion Date

January 15, 2032

Conditions
Paraneoplastic Neurological SyndromeAutoimmune Encephalitis
Interventions
BIOLOGICAL

Test of biological samples

Different tests can be use on biological sample : western bloc, dot blot, immune-fluorescence, immunoprecipitation, CBA, functional test, epitope research, IgG title

Trial Locations (1)

69677

Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes, Lyon

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER